The advent of mRNA-based therapeutics has transformed biotechnology and medicine, promising novel treatments for various diseases. (1,2) This advancement stems from the development of efficient ...

Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Laboratory for Clinical Medicine, Chinese Institutes for Medical Research, Ministry of Science and Technology, Collaborative ...

bDivision of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands Years of research exploring mRNA vaccines for cancer treatment in preclinical and clinical trials have set the stage ...

Moderna is currently in the very early stages of testing a bird flu vaccine using the same mRNA technology that allowed for rapid development and rollout of COVID-19 vaccines. The funds from the U.S.

Patients given experimental mRNA jabs for HIV have developed an 'unexpected' side-effect needing further investigation, experts say. About 7 per cent of volunteers given the jabs in the trial ...

That’s where Microsoft Visio comes in—a tool designed to simplify the process of creating professional diagrams and flowcharts, even if you’re not a design expert. If you’ve been curious ...

Therefore, safer and more effective novel preventive immunizations are essential for the prevention and management of FMD. The mRNA has demonstrated the ability to induce immunological activation both ...

Merck KGaA has sealed a $3.9bn deal to acquire SpringWorks. Credit: LumiNola via Getty Images. Merck KGaA (Merck) has moved to strengthen its position in oncology and rare diseases with a $3.9bn ...

Official repository for the paper "MathVerse: Does Your Multi-modal LLM Truly See the Diagrams in Visual Math Problems?". 🌟 For more details, please refer to the project page with dataset exploration ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am ...

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA ...